Overview

Treatment and Outcome of Early Onset Bipolar Disorder

Status:
Completed
Trial end date:
2006-08-01
Target enrollment:
Participant gender:
Summary
This study will compare the effectiveness in the maintenance of continuing adjunctive atypical antipsychotic medication compared to traditional mood stabilizer(s) alone in the maintenance treatment of adolescents with bipolar disorder.
Phase:
Phase 4
Details
Lead Sponsor:
Northwell Health
Collaborator:
National Institute of Mental Health (NIMH)
Treatments:
Olanzapine
Quetiapine Fumarate
Risperidone
Valproic Acid
Ziprasidone